XTalks

NOVEMBER 19, 2024

In clinical research, diversity is more than a prerequisite for a successful drug — it’s a critical component that enhances the validity and applicability of clinical trial outcomes. With its recent draft guidance, the FDA has vitalized the importance of inclusive research, adding growing recognition to diversity’s role in clinical trials.

Clinical Trials

Scienmag

JUNE 12, 2025

view more Credit: Osaka Metropolitan University Even the best products won’t meet expectations if they are packed poorly — packaging matters. Employing Raman spectroscopy to scrutinize these contrasting behaviors, the researchers found that solvent polarity influences molecular vibrations within the MOF structures.

Drug Delivery

Pharmaceutical Technology

JUNE 24, 2025

In the Research & Development category, i3 Membrane was honored for its efforts to scale DMC for commercial therapeutic drug manufacturing, demonstrating superior performance and efficiency. This preservation of molecular quality is vital for ensuring the safety and effectiveness of therapeutic products.

Manufacturing

ACRP blog

MARCH 12, 2025

The benefits of diversity and inclusion in clinical research are widely recognized, yet the financial and operational costs of these efforts are often overlooked. Another hidden cost is training and education for research teams, says Mitchell Hilbe, CEO/Co-Founder at DiversiTrials. These will be more important than ever if current U.S.

Clinical Research

Pharmaceutical Technology

JUNE 26, 2025

This capability allows researchers to prioritize one billion molecules in as little as one day, compared to one million days with conventional methods. By prioritizing molecules for physics-based analyses, researchers can catch potential issues earlier in the drug discovery process, further enhancing efficiency and reducing costs.

Drugs

Pharmaceutical Technology

JUNE 12, 2025

Robert Barrie June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The pact is a significant moment for Novo Nordisk, pouring significant resources into research that is not centred around incretins. Deep Apple is also in line to receive royalties on sales on any products borne from the partnership that reach market.

Research

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Find out more Introduced by the Medicines and Healthcare products Regulatory Agency (MHRA), it will allow patients to receive personalised treatments made at their hospital, clinic or near their homes.

Manufacturing

Drug Patent Watch

MARCH 12, 2025

Behind the scenes, generic drug manufacturers are working tirelessly to ensure that their products are safe, effective, and identical to their branded counterparts. It helps them to identify potential issues early on, make adjustments as needed, and ultimately bring a high-quality product to market.

Generic Drugs

Scienmag

JUNE 24, 2025

As the quest for healthier eating continues to gain momentum, a new study sheds light on a concerning reality in the American food landscape—19% of packaged foods and beverages are tainted with synthetic food dyes. These include confectionery items, sugar-sweetened beverages, ready-to-eat meals, breakfast cereals, and popular baked goods.

Containment

Scienmag

JUNE 14, 2025

In a groundbreaking leap forward for soft robotics and flexible electronics, a team of researchers led by W. The research team employed a composite polymer matrix embedded with magnetic nanoparticles, enabling wireless control via external magnetic fields. Ding, and Y.

Engineer

Pharmaceutical Technology

JULY 28, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Hengrui Pharma is also set to receive tiered royalties on worldwide product net sales, with certain regional exclusions. ” Beyond HRS-9821, the collaboration includes up to 11 additional programmes.

Clinical Trials

Pharmaceutical Technology

JUNE 13, 2025

The partnership strengthens GSK’s current relationship with the Indian company, which began with a product transfer and licence agreement in 2021 for the malaria vaccine, RTS,S. ” Shigellosis, caused by Gram-negative Shigella, leads to severe intestinal infection with symptoms of diarrhoea, fever and abdominal pain.

Vaccination

XTalks

JULY 10, 2025

Potency assays play a vital role in biopharmaceutical development by measuring a drug candidate’s biological activity against a reference standard — offering essential insights into product quality and its potential clinical success. In early development, they support candidate selection and help optimize formulations.

Bioassay

The Pharma Data

JULY 2, 2025

HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the official launch of WuXiHigh™ 2.0 , a next-generation, high-throughput formulation development platform specifically engineered for high-concentration biologics. WuXi Biologics Launches WuXiHigh™ 2.0 WuXiHigh™ 2.0: WuXiHigh™ 2.0:

FDA Approval

Pharmaceutical Technology

JUNE 25, 2025

Over the past few decades, Alzheimer’s research and development (R&D) has seen a low success rate due to failure to demonstrate efficacy in clinical trials. Go deeper with GlobalData Reports Biosimilars in Pharmaceuticals: Peptide-based compositions for Alzh. Give your business an edge with our leading industry insights.

Clinical Trials

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Early collaborations Several pharmaceutical companies have begun exploring quantum computing through research partnerships and pilot projects.

Protein

Pharmaceutical Technology

JUNE 18, 2025

With the launch, Genomics claims its test is the first product in the country to be registered with the Medicines and Healthcare products Regulatory Agency (MHRA) and carry the UK Conformity Assessed (UKCA) mark, combining genetic testing and clinical data to enable prediction and prevention.

Genomics

Pharmaceutical Technology

JULY 28, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? GlobalData forecasts that by 2034, pipeline products, including sonelokimab and povorcitinib will represent 47.3% CAGR is largely attributed to the launch of novel biologics and small molecules.

Marketing

XTalks

APRIL 15, 2025

In a recent interview, Anthea Cherednichenko, MPH, MBA, Vice President, Hematology Franchise Head at Takeda, shared insights with Xtalks into the evolving clinical trial environment, the role of technology and the importance of partnerships in advancing rare disease research, particularly in blood and bleeding disorders.

Trials

Pharmaceutical Technology

JUNE 25, 2025

City of Hope National Medical Center’s radiology professor Phillip Kuo said: “The use of quantification in amyloid PET imaging has steadily moved from research to clinical practice, where it can aid in more confident and accurate diagnosis. Give your business an edge with our leading industry insights.

Clinical Trials

Pharmaceutical Technology

JUNE 25, 2025

The CDC’s capacity to monitor public health needs is critical, particularly as manufacturers navigate the intricate landscape of vaccine production and regulatory compliance. Reports Sustainability in Healthcare - Thematic Research Data Insights The gold standard of business intelligence.

Vaccination

Pharmaceutical Technology

JULY 24, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? It’s not just about efficiency, it’s about creating space for better decisions and better outcomes,” says Walker Bradham, senior director of product management and design at Zelta.

Clinical Trials

Scienmag

JUNE 25, 2025

Spearheaded by researchers at the University of Notre Dame, this comprehensive pharmaceutical evaluation reveals significant discrepancies in the active pharmaceutical ingredient (API) content of chemotherapy drugs sourced from countries including Cameroon, Ethiopia, Kenya, and Malawi.

Drugs

Pharmaceutical Technology

JUNE 25, 2025

June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The research is supported by John Dimitri Research Foundation for Congenital Heart Disease and Big Hearts 2 Little Hearts. Credit: shisu_ka/Shutterstock.

Clinical Trials

Pharmaceutical Technology

JUNE 25, 2025

Fresh off a regulatory victory for a new HIV product, Gilead is shifting focus to the oncology space – signing a deal worth up to $750m to license a solid tumour treatment candidate from Kymera Therapeutics. Credit: Sundry Photography via Shutterstock.

Drugs

Roots Analysis

MAY 28, 2025

Drone delivery, one such rapidly emerging area, is gaining a lot of market traction Introduction to Autonomous Deliveries Autonomous delivery refers to the use of self-driving delivery vehicles, drones or robots to transport goods, packages or products to your doorstep, without any human intervention.

Packaging

Pharmaceutical Technology

JUNE 25, 2025

Currently, patient data within Europe is managed on a country-to-country basis, which can create barriers to research. This legislation would abolish these barriers and could improve research and understanding of the prevalence and treatment of both common and rare diseases.

Regulation

Pharmaceutical Technology

JULY 1, 2025

Experts praise the reforms to rare disease and antimicrobial research, but they worry that some provisions in the EU Pharma Package may harm innovation on the continent, contrary to its stated objectives. In a bid to chase competitiveness, the EU is advancing its most drastic revision of pharmaceutical law in 20 years.

Pharma Packaging

PharmTech

JULY 17, 2025

Stage 1: design the compounding blueprint Establish a complete plan including ingredients, packaging, calculations, labeling, and patient-specific factors. Stage 4: packaging & patient-ready delivery Assemble patient/client information equivalent to commercial products.

Manufacturing

PharmTech

JUNE 19, 2025

The new facility will feature state-of-the-art cleanroom packaging and high-sensitivity analytical testing capabilities. These will allow the company to customize chemistries for product development and provide more tightly controlled parameters beyond compendial limits and a validated control system, according to a press release (1).

Manufacturing

PharmTech

JULY 15, 2025

Unparalleled Expertise and Transparency Drive a Unique Development, Manufacturing, and Clinical Supply Experience Experic July 15th 2025 Article Step into a model designed for adaptability, speed, and success in specialized drug development.

Development

Pharmaceutical Technology

JUNE 6, 2025

Juvenescence has acquired drug discovery company Ro5, a move that enhances its AI/machine learning capabilities and improves research and development capabilities. Credit: Collagery/Shutterstock. Give your business an edge with our leading industry insights.

Drugs

Pharmaceutical Technology

JUNE 20, 2025

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine development by leveraging local health-tech ecosystems and research infrastructure. The MoU was signed at the BIO International Convention 2025 in Boston, in the US state of Massachusetts.

Vaccination

XTalks

JANUARY 23, 2025

Due to pressure, pharma giants Eli Lilly , Sanofi and Novo Nordisk agreed to cap the price of their insulin products to $35 beginning in 2023, marking cuts of up to 70% of the original prices. Lawmakers from both US political parties are hoping to enact PBM reform this year, after it was excluded from a federal funding package last month.

Generic Drugs

PharmTech

JUNE 6, 2025

Image source: ©huiying - stock.adobe.com Biopharmaceutical product development is burgeoning with developments in treatment approaches, chemistries, and vectors giving companies new strategies for targeting disease. ICH Q6B provides a clear framework for expectations regarding the structural characterization of biopharmaceutical products (2).

Manufacturing

PharmTech

JULY 15, 2025

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind (..)

Marketing

The Pharma Data

JUNE 24, 2025

securing a funding package of up to $2 billion. Rather than diluting ownership or yielding developmental control to a larger pharmaceutical partner, Revolution Medicines is leveraging this funding arrangement to maintain autonomy over its research, development, and eventual commercialization efforts.

Medicine